Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,691Revenue $M778Net Margin (%)22.6Z-Score17.8
Enterprise Value $M2,504EPS $2.3Operating Margin %35.3F-Score7
P/E(ttm))16.4Cash Flow Per Share $1.4Pre-tax Margin (%)35.7Higher ROA y-yY
Price/Book3.910-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %26.5Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow19.2y-y EBITDA Growth Rate %29.1ROA % (ttm)22.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)24.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M72.8ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNAndreas Halvorsen 2014-06-30 Buy 0.23%$33.1 - $42.21
($37.18)
$ 36.96-1%New holding, 1330294 sh.1,330,294
MYGNJohn Burbank 2014-06-30 Buy 0.01%$33.1 - $42.21
($37.18)
$ 36.96-1%New holding, 16676 sh.16,676
MYGNRichard Snow 2014-06-30 Reduce-0.96%$33.1 - $42.21
($37.18)
$ 36.96-1%Reduce -39.96%1,091,227
MYGNJohn Griffin 2014-06-30 Sold Out -0.38%$33.1 - $42.21
($37.18)
$ 36.96-1%Sold Out0
MYGNJean-Marie Eveillard 2014-06-30 Sold Out -0.03%$33.1 - $42.21
($37.18)
$ 36.96-1%Sold Out0
MYGNJohn Griffin 2014-03-31 Buy 0.38%$20.79 - $38.17
($30.6)
$ 36.9621%New holding, 1000000 sh.1,000,000
MYGNRichard Snow 2014-03-31 Add0.37%$20.79 - $38.17
($30.6)
$ 36.9621%Add 18.11%1,817,401
MYGNJean-Marie Eveillard 2014-03-31 Buy 0.03%$20.79 - $38.17
($30.6)
$ 36.9621%New holding, 284826 sh.284,826
MYGNThird Avenue Management 2014-03-31 Sold Out -0.13%$20.79 - $38.17
($30.6)
$ 36.9621%Sold Out0
MYGNRichard Snow 2013-12-31 Add1.29%$20.79 - $30.65
($25.36)
$ 36.9646%Add 10989.6%1,538,685
MYGNJoel Greenblatt 2013-12-31 Add0.18%$20.79 - $30.65
($25.36)
$ 36.9646%Add 36.27%1,316,314
MYGNThird Avenue Management 2013-12-31 Buy 0.13%$20.79 - $30.65
($25.36)
$ 36.9646%New holding, 328314 sh.328,314
MYGNRonald Muhlenkamp 2013-12-31 Sold Out -2.3%$20.79 - $30.65
($25.36)
$ 36.9646%Sold Out0
MYGNJoel Greenblatt 2013-09-30 Add0.32%$24.396 - $31.8
($28.51)
$ 36.9630%Add 74.78%965,987
MYGNRichard Snow 2013-09-30 Buy 0.02%$24.396 - $31.8
($28.51)
$ 36.9630%New holding, 13875 sh.13,875
MYGNRonald Muhlenkamp 2013-06-30 Buy 2.7%$24.35 - $34.26
($28.98)
$ 36.9628%New holding, 481900 sh.481,900
MYGNRon Baron 2013-06-30 Sold Out -0.09%$24.35 - $34.26
($28.98)
$ 36.9628%Sold Out0
MYGNJoel Greenblatt 2013-03-31 Add0.24%$24.19 - $27.68
($25.95)
$ 36.9642%Add 62.99%489,388
MYGNRon Baron 2013-03-31 Buy 0.09%$24.19 - $27.68
($25.95)
$ 36.9642%New holding, 658653 sh.658,653
MYGNJoel Greenblatt 2012-03-31 Add0.22%$20.36 - $25.64
($21.82)
$ 36.9669%Add 40.27%363,079
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYGN John Burbank 2014-06-3016,6760.020.01New Buy
MYGN Andreas Halvorsen 2014-06-301,330,2941.830.23New Buy
MYGN Joel Greenblatt 2014-06-301,117,3511.530.54-7.36%
MYGN Richard Snow 2014-06-301,091,2271.51.5-39.96%
MYGN John Griffin 2014-06-30000Sold Out
MYGN Jean-Marie Eveillard 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Evans James SCFO 2014-09-30Sell21,850$38.99-2.59view
Evans James SCFO 2014-09-24Sell8,790$37.980view
Evans James SCFO 2014-09-23Sell110,463$37.890.24view
LANCHBURY JERRY SChief Scientific Officer 2014-07-14Sell20,000$39.85-4.69view
MELDRUM PETER DPresident & C.E.O. 2014-07-14Sell24,000$39.5-3.85view
HENDERSON JOHN TDirector 2014-06-05Sell5,000$35.76.39view
Rogers Ronald S.Exec VP Corp Communications 2014-05-09Sell12,500$36.015.47view
MARSH RICHARD ME.V.P., General Counsel 2014-04-30Sell30,000$41.8-9.14view
MARSH RICHARD ME.V.P., General Counsel 2014-04-23Sell31,516$39.8-4.57view
MARSH RICHARD ME.V.P., General Counsel 2014-04-16Sell28,484$39.8-4.57view

Press Releases about MYGN :

    Quarterly/Annual Reports about MYGN:

    News about MYGN:

    Articles On GuruFocus.com
    Chuck Royce Comments on Myriad Genetics Oct 08 2014 
    Chuck Royce’s Royce Premier Fund Second Quarter 2014 Manager Commentary Oct 08 2014 
    Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
    Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
    Surfing for Billionaire Bargains Sep 22 2013 
    Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
    RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
    Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
    Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 
    Myriad Genetics Inc. (MYGN) CFO James S Evans sells 8,400 Shares Mar 12 2010 


    More From Other Websites
    Myriad Genetics to Announce 1Q15 Financial Results on November 4, 2014 Oct 21 2014
    Myriad Genetics to Announce 1Q15 Financial Results on November 4, 2014 Oct 21 2014
    Weakness Seen in Myriad (MYGN): Stock Tumbles 7.2% Oct 20 2014
    Gene tester obtains coverage Oct 17 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Oct 17 2014
    Myriad Gets Reimbursement OK On Prostate Cancer Test Oct 17 2014
    These companies are missing out on the rally Oct 17 2014
    Myriad Receives Draft Medicare Coverage for Prolaris(R) Oct 17 2014
    Myriad Receives Draft Medicare Coverage for Prolaris(R) Oct 17 2014
    Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% Oct 15 2014
    MiMedx Group (MDXG) Worth Watching: Stock Rises 9.7% Oct 15 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Oct 09 2014
    A Cutting-Edge Medical Stock That's Incredibly Undervalued Oct 09 2014
    Myriad Appoints R. Bryan Riggsbee As CFO Oct 08 2014
    Myriad Appoints R. Bryan Riggsbee as Chief Financial Officer Oct 08 2014
    Myriad Presents Tumor BRACAnalysis CDx(TM) Study at ESMO Sep 29 2014
    Myriad Genetics Poised on Strong myRisk, Overseas Results Sep 26 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Sep 24 2014
    Myriad Genetics Posts Encouraging myPath Melanoma Data Sep 10 2014
    Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in... Sep 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Antoniy
    ReplyAntoniy - 9 months ago
    hs
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK